StemCells Inc (STEM) stock plummeted on Tuesday following an announcement about one of its Phase II studies. StemCells said that it will no longer be pursuing its Phase II Pathway Study that was focused on spinal cord injuries. It …
Jake Jackson, 14, knows a lot about pigs. From feeding to breeding, he's spent his whole life around the farm, first with horses, now with his pigs. Jake is attending the National Western Stock Show, competing in the hog competitions, …
... agency received $443,500 in total compensation from the Bay Area stem cell company that appointed him to its board of directors only seven days after he left his state post. The stock and cash were provided over a two-year period to …
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here. StemCells, Inc. (NASDAQ: STEM) announced the pricing of an …
When Nasdaq sneezes, world stock markets catch a cold ... Nor can they any longer stand by and refuse to assist world authorities as they seek to stem the …
CARLSBAD, CA--(Marketwired - July 28, 2015) - International Stem Cell Corporation (ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that it …
They also received patent on placental stem cell recovery. The stock has recently generated negative earnings. Cytori Therapeutics, Inc. (NASDAQ:CYTX) is a $68 million market cap company that makes and markets regenerative …
Option traders' bets likely stem from the positive outlook analysts have on the stock, with earnings expected to climb by 67% in fiscal 2019 to $2.26 per share on …